“TOCILIZUMAB AS MONOCLONAL ANTIBODY THERAPY IN OVERCOMING ACUTE RESPIRATORY DISTRESS SYNDROME IN COVID-19 PATIENTS”. JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia 9, no. 3 (April 5, 2022): 92–101. Accessed May 13, 2026. https://jimki.bapin.or.id/main/article/view/488.